Cite

APA Citation

    Postow, M. (n.d.). reduced-dose ipilimumab with standard-dose pembrolizumab: is less more?. Lancet oncology, 18(9), 1144–1145. http://access.bl.uk/ark:/81055/vdc_100049766224.0x000051
  
Back to record